Navigation Links
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
Date:6/4/2011

*4 patients in the Q14 day arm with no post-baseline scans, but no evidence of progression were excluded from analysis in the evaluable population.

**based on a Kaplan-Meier analysis for the intent-to-treat population.

Figure B: Efficacy Table: Response rate by prior therapyPrior Therapy Subgroup

Response by RECIST v 1.0

Evaluable PatientsNKTR-102

145 mg/m2

q14d

N=31

NKTR-102

145 mg/m2

q21d

N=35TOTALN=66Prior A/T only

ORR (confirmed)

7/22 (32%) 5/21 (24%)12/43 (28%)Prior A/T in MBC

ORR (confirmed)

3/7 (43%)2/9 (22%)5/16 (31%)Prior A/T/C

ORR (confirmed)

2/6 (33%)3/10 (30%)5/16 (31%)Figure C: Efficacy Table: Response rate by tumor characteristicsDisease Subgroup

Response by RECIST v 1.0

Evaluable PatientsNKTR-102

145 mg/m2

q14d

N=31

NKTR-102

145 mg/m2

q21d

N=35TOTALN=66ER+ and/or PR+

ORR (confirmed)

8/21 (38%) 4/21 (19%)12/42 (29%)Triple-negative breast cancer

ORR (confirmed)

2/8 (25%)5/10 (50%)7/18 (39%)Visceral Disease

ORR (confirmed)

8/25 (32%)9/32 (28%)17/57 (30%)Figure D: Safety Table: Safety-Summary of Drug Related AEsMost Common Drug-related Grade 3 and 4 Adverse Events > 5% or event of interest

N (%) NKTR-102

145 mg/m2

q14d

N=35

NKTR-102

145 mg/m2

q21d

N=35Grade 3

Grade 4

Grade 3

Grade 4Diarrhea

6 (17%)

1 (3%)

8 (23%)

0Neutropenia

2 (6%)

2 (6%)

3 (9%)

1 (3%)Dehydration

3 (9%)

0

4 (11%)

0Fatigue

4 (11%)

0

3 (9%)

0Vomiting

3 (9%)

0

0

0Anaemia

1 (3%)

0

0

1 (3%)Asthenia

2 (6%)

0

0

0Lethargy

2 (6%)

0

0

0Lymphopenia

1 (3%)

1 (3%)
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
2. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
3. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
4. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
5. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
6. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
9. NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
10. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
11. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Mark Riccio, director of ... facility, is using the online crowd-funding platform Kickstarter ... imaging to researchers and would-be superheros everywhere: "for ... would YOU do if you had Superman,s X-ray ... and explorers everywhere, from elementary through high school ...
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ... company, announced today that it has completed integration ... solution for Plastic Surgery and Dermatology practices. ... more value to healthcare practices using Nextech," stated ... eRelevance Corporation. "Using information from the EMR we ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... WARREN, N.J., Jan. 17, 2012 Roka Bioscience announced ... AOAC Performance Tested Method(SM) certification from the ... was conducted by Silliker, Inc., as part of the ... The Roka Listeria Detection Assay runs on the ...
... Positron Corporation (OTCBB: POSC), a leading molecular imaging company ... to announce the acquisition of Manhattan Isotope Technology, LLC ... operations and retained all employees of MIT. In exchange, ... and earn-out consideration of $3,500,000 based on 20 percent ...
Cached Medicine Technology:Roka Bioscience Awarded AOAC-RI Certification for Roka Listeria Detection Assay 2Positron Finalizes Acquisition of Manhattan Isotope Technology, LLC 2Positron Finalizes Acquisition of Manhattan Isotope Technology, LLC 3
(Date:8/22/2014)... (PRWEB) August 23, 2014 2014 ... is a professional and in-depth research report on ... Glucose Meter information, including Glucose Meter definition, classification, ... industry overview. This research covers the international market ... industry analysis covering macroeconomic environment & economic situation ...
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online ... Health Plans. , According to Zane Benefits, employers are ... lower the cost of healthcare without reducing coverage for ... however, can be confusing. , The new guide contains ... main types of ABHPs. It also explains the ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... that is written by marketing experts for marketers to ... links has caught the attention of Shane Michaels, prompting ... with Internet marketing in any way knows that content ... in the industry,” reports Michaels. “But even though content ...
(Date:8/22/2014)... Sacramento, CA (PRWEB) August 22, 2014 Buying ... to an adult who is unsure about available coverage types ... now providing principal life insurance policy pricing to the public ... The use of this tool is free and is expected ... are available to the public throughout the U.S. The system ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group has recently ... a high level of drug use among teenagers. The treatment ... drug addiction and work to minimize drug abuse. , America ... and drug addiction in history. According to the National ... million Americans aged 12 or older—or 9.2 percent of the ...
Breaking Medicine News(10 mins):Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... a 27% Increase in Revenues, DALLAS, Oct. 30 ... of Internet-based claims,processing solutions for the healthcare industry, today ... ended September 30, 2008., "We are pleased to ... Don Crosbie, chief executive officer of Claimsnet.,"The increase in ...
... Philips,Electronics (NYSE: PHG , AEX: PHI) today ... offer quick relief from seasonal mood-related,problems. With the ... affected,by the increased darkness and experience what is ... blues may include lethargy, lowered mood, problems,sleeping, carbohydrate ...
... Mylan Inc. (NYSE: MYL ),today announced that ... company has declared its quarterly dividend of $16.25 per,share ... a liquidation,preference of $1,000.00 per share) payable on Nov. ... of Oct. 31, 2008., Mylan Inc., which provides ...
... VIRGINIA BEACH, Va., Oct. 30, 2008 AMERIGROUP,Corporation (NYSE: ... in the,17th Annual Credit Suisse Healthcare Conference on November ... Company,s presentation, which begins Thursday,November 13 at 4:00 p.m. ... http://www.amerigroupcorp.com, on the investors, page. A replay will,be ...
... age of disease onset and nerve cell death , , ... genes may be linked to the most common form ... team, from Massachusetts General Hospital-MassGeneral Institute for Neurological Disease ... families with a history of the devastating neurological disorder. ...
... Oct. 30 WellPoint,s commercial marketing,team was awarded ... Association,(DMA) for its innovative campaign, "Ecosphere -- Simple ... International ECHO Awards competition is the only international,award ... creativity,strategy and response results., WellPoint,s campaign, conducted ...
Cached Medicine News:Health News:Claimsnet.com Reports Third Quarter 2008 Results 2Health News:Claimsnet.com Reports Third Quarter 2008 Results 3Health News:Philips Introduces New, Advanced Light Therapy Device to Offer Quick Relief from Winter Blues 2Health News:Philips Introduces New, Advanced Light Therapy Device to Offer Quick Relief from Winter Blues 3Health News:Scientists Spot 4 New Alzheimer's Genes 2Health News:WellPoint Awarded Prestigious International Marketing Award 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: